Successive thyroid storms treated with L-carnitine and low doses of methimazole [5]

American Journal of Medicine

Volumn 115, Issue 5, 2003, Pages 417-418

  Benvenga, Salvatore ^a   Lapa, Daniela ^a   Cannavò, Salvatore ^a   Trimarchi, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARNITINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PROPYLTHIOURACIL; THIAMAZOLE; THYROID HORMONE; ANTITHYROID AGENT;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; EUTHYROIDISM; FAMILY HISTORY; HOSPITAL ADMISSION; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LETTER; LOW DRUG DOSE; MALE; MYOCARDITIS; PRIORITY JOURNAL; THROMBOPHLEBITIS; THYROID CRISIS; TREATMENT OUTCOME;

ADULT; ANTITHYROID AGENTS; CARNITINE; HUMANS; MALE; METHIMAZOLE; THYROID CRISIS;

EID: 0142181039     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00399-1     Document Type: Letter

References (7)

1. Famularo G., Matricardi F., Nucera E., Santini G., De Simone C. Carnitine deficiency primary and secondary syndromes . De Simone C., Famularo G. Carnitine Today. 1997;119-161 RG Landes, Austin, Texas.
2. Benvenga S., Lakshmanan M., Trimarchi F. Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake. Thyroid. 12:2000;1043-1050.
3. DeFelice S.L., Gilgore S.G. The antagonistic effect of carnitine in hyperthyroidism. Preliminary report. J New Drugs. 6:1966;351-353.
4. Benvenga S., Ruggeri R.M., Russo A., et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism. A randomized, double blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 86:2001;3579-3594.
5. Wartofsky L. Thyrotoxic storm. Braverman L.E., Utiger R.D. Werner and Ingbar's The Thyroid A Fundamental and Clinical Text . 8th ed:2000;679-684 Lippincott Williams & Wilkins, Philadelphia, Pennsylvania.
6. Kragie L. Membrane iodothyronine transporter. Part I. Review of physiology. Endocr Res. 20:1994;319-341.
7. Hagag P., Nissembaum H., Weiss M. Role of colestipol in the treatment of hyperthyroidism. J Endocrinol Invest. 21:1998;725-731.